Ignis Therapeutics (Suzhou) Limited

Primary objective: To evaluate the pharmacokinetic characteristics of apomorphine hydrochloride injection (subcutaneous injection) of 1 mg, 2 mg, and 3 mg in healthy Chinese subjects; Secondary objective: To evaluate the safety and tolerability of apomorphine hydrochloride injection (subcutaneous injection) of 1 mg, 2 mg, and 3 mg in healthy Chinese subjects.

Primary objective: To evaluate the pharmacokinetic (PK) characteristics of a single oral dose of 37.5 mg, 75 mg and 150 mg of Soanfeituo tablets in healthy Chinese subjects. Secondary objective: To evaluate the safety and tolerability of a single oral dose of 37.5 mg, 75 mg and 150 mg of Soanfeituo tablets in healthy Chinese subjects.